Summary
Background: The impact of the utilisation of such e-health approaches, including mHealth (use of mobile phones and other wireless technology in the delivery of medical care) assessments of health parameters, or the use of decision aids and online risk calculators over time have not been previously described. The objective of this analysis is to assess the time trends in use of the CHADS 2 and CHA 2 DS 2 VASc scores in e-health, and the geographical and specialty uptake of these scores, using data gleaned from a popular online clinical decision tool and medical reference, MDCalc.
We hypothesised that the change in use of the scores would reflect the changes in guidelines and trends in clinical practice.
Results:
The CHA 2 DS 2 VASc score was the 20th most popular calculator in 2012, rising to the second most popular calculator in 2018; the CHADS 2 score showed the converse, dropping from no. 3 to no. 22. Use of the CHA 2 DS 2 VASc scores particularly increased in the United States, Canada and Australia over time while the United Kingdom experienced a greater traffic share in 2015. The majority users of the CHADS 2 and CHA 2 DS 2 VASc scores were primary care physicians, with cardiologists being in the minority; the proportion of cardiologists was greater outside USA, compared to within USA.
Conclusion:
Over time, use of the CHA 2 DS 2 VASc score increased, while use of the CHADS 2 score decreased. The change in uptake could partly be related to introduction of guidelines recommending the use of the CHA 2 DS 2 VASc score for stroke risk stratification.
The objective of this analysis is to assess the time trends in use of the CHADS 2 and CHA 2 DS 2 VASc scores in e-health, and the geographical and specialty uptake of these scores, using data gleaned from a popular online clinical decision tool and medical reference, MDCalc. We hypothesised that the change in use of the scores would reflect the changes in guidelines and trends in clinical practice.
| ME THODS

| Study design
A retrospective study was carried out using usage data from a popular online clinical decision tool and medical reference, MDCalc 
| Analytics platform
Data were collected for visits to the mdcalc.com website and MDCalc iOS and Android apps in 1 month intervals using the statistics tool Google Analytics. The relevant Google Analytics metrics used in this study include:
| User
This Google Analytics metrics attempts to count how many unique individuals access MDCalc in a given time. Specifically, it's typically tracked using an "electronic cookie" that's managed by Google Analytics. 
| Data collection and processing
In this study, data were collected for Users, specific MDCalc pages 
| User adoption
The data were examined in two groups, (a) Users who visited the CHA 2 DS 2 -VASc Score and (b) Users who visited the CHADS 2 Score.
The data for both groups were normalised as explained in the following section. MDCalc did not specifically promote either CHADS 2 or CHA 2 DS 2 -VASc Scores during the study period.
| Normalisation
Medical calculator and reference popularity has risen dramatically over the last decade as technology is increasingly adopted in the clinician workflow. In addition, with time, physicians have become more tech savvy and more evidence based, both of which have led to a large increase in the usage of EBM electronic medical references such as MDCalc. Therefore, in order to capture the relative use and popularity of specific scores, data must be normalised to account for these trends. The approach to normalisation also took into account that sometimes specific calculators are replaced by newer calculators-for reference in the 
What's new
• Over time, use of the CHA 2 DS 2 VASc score increased, while use of the CHADS 2 score decreased. The change in uptake could partly be related to introduction of guidelines recommending the use of the CHA 2 DS 2 VASc score for stroke risk stratification. aforementioned time periods were chosen for two reasons: first, both scores were available on MDCalc during these periods, second, the 2012 ESCG Guidelines for the management of AF (the first major guideline formally recommending the CHA 2 DS 2 -VASc Score) had not yet been published.
| Per country adoption
In order to evaluate when the CHA 2 DS 2 -Vasc Score and the CHADS 2 Score were adopted in specific countries, per country User data from 
| Per specialty adoption
User specialty data are available on Google Analytics for logged in Users, a requirement for the iOS and Android app. For Users who visited the CHA 2 DS 2 -Vasc Score, User specialties, as reported by Users at registration, were collected for both the U.S. and Ex-U.S. 
| RE SULTS
| Per specialty adoption of CHA 2 DS 2 -VASc and CHADS 2 scores
The CHA 2 DS 2 -VASc Score and CHADS 2 Scores were used most frequently by primary care providers and then cardiologists, 
| D ISCUSS I ON
In this analysis, our principal findings are as follows: (a) the 
| Limitations
Using cookies allows analytics.js to identify unique users across browsing sessions, but it cannot identify unique users across different browsers or devices. The specialty data is only app data (which were missing from 3 March 2016 to 2 march 2017)
although overall trends for specialty use should be a reasonable representation of users. In some countries, the lack of data does not necessarily mean no usage, but lack of access may be a factor. 
| CONCLUSION
